HAVN Life Logo White

The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-disciplinary collaboration
creating positive experiences and outcomes.


Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.


Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.

350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies

The partnership will further industry growth for naturally derived psilocybin Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” …

Read More →
Press Releases

HAVN Life Sciences TO Present at Q3 Investor Summit Virtual Conference

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”) a biotechnology company developing natural health products …

Read More →
Press Releases

HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility

HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common …

Read More →
Scroll to Top